The popularity of direct-to-consumer (DTC) channels across industries has fueled patients’ expectations for convenience, cost savings, and improved access to healthcare services. While the COVID-19 pandemic cemented the idea that telemedicine can be a critical part of a pharmaceutical brand’s go-to-market strategy, it’s essential to recognize that it is just one piece of the puzzle. To truly transform the patient experience and improve brand outcomes, pharmaceutical brand teams need to integrate a telemedicine channel within a broader DTC strategy
We recently caught up with Andrew Duncan, our SVP of Business Operations, Pricing, and Strategic Finance. Andrew shares how his personal connection with Phil’s mission is what he likes most about his role and a recent success that he is particularly proud of. Please tell us a little bit about yourself and your role at Phil
The pharmaceutical industry has undergone a digital transformation – as of 2024, over 75% of patients have accessed care virtually. Leading brands across the industry are embracing direct-to-consumer (DTC) programs to meet modern patient needs. If you’re not considering how this access strategy could benefit your stakeholders, you may be missing out on the opportunity to better serve your patients and providers while driving brand performance
We are excited to introduce Glenn Boyer, VP of Business Development, who recently joined our team to support growth. In his interview, Glenn discusses his extensive experience in the pharmaceutical industry and why he believes Phil’s approach to digital hub transformation is the best approach. Please tell us a little bit about yourself and your role at Phil
Renee Kasun recently joined our team as Vice President of Business Development, bringing over 20+ years of sales experience. Discover how Renee plans to leverage her industry expertise to support growth at Phil. Please tell us a little bit about yourself and your role at Phil
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.